WCM
FBT icon

Winebrenner Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Winebrenner Capital Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+831
New +$179K 0.13% 142

Other funds holding FBT

JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
OPAM
Ocean Park Asset Management Santa Monica, California $2.08B AUM 5.32% 1-Year Est. Return
QCIG
Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FEG
Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return
TCOO
Trust Company of Oklahoma Tulsa, Oklahoma $389M AUM 34.72% 1-Year Est. Return
SP
Stablepoint Partners Braintree, Massachusetts $723M AUM 29.31% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
IWM
Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return

Winebrenner Capital Management's FBT Position: Q2 2026 in Review

Winebrenner Capital Management opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 831 shares worth $206K. The stake represents 0.13% of the portfolio and ranks #142 among its holdings.

51 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Winebrenner Capital Management held 831 shares of First Trust NYSE Arca Biotechnology Index Fund worth $206K as of Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Winebrenner Capital Management position in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.13% of Winebrenner Capital Management's portfolio in Q2 2026, its #142 holding.
  • 51 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Winebrenner Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.